Market Overview

Akorn Shares Rally Following Increased Price Target

Share:
Related AKRX
John Kapoor, Founder Of Insys, Indicted On Charges Of Bribing Doctors To Overprescribe Opioids
Watch These 8 Huge Call Purchases In Thursday Trade

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Latest Ratings for AKRX

DateFirmActionFromTo
Apr 2017PiperJaffrayDowngradesOverweightNeutral
Apr 2017JefferiesDowngradesBuyHold
Apr 2017William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings

 

Related Articles (AKRX)

View Comments and Join the Discussion!